RYAN MACKINNON VASAPOLI AND BERZOK, LLP for GENENTECH
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 2nd Quarter - Report | Jul 21, 2008 | $50,000 | Replaced |
| 2nd Quarter - Amendment (this page) | Aug 18, 2009 | $50,000 | Yes |
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Pharmacy PHA
Issues regarding follow on biologics, HR 5629 Pathway for Biosimilars Act; S 1695 Biologics, Price Competition and Innovation Act of 2007, HR 1956 - provide for approval of similar biological products, HR 5629 - establish a pathway for the licensure of biosimilar biological products, HR 1038 - provide for licensing of comparable and interchangeable biological products
| Lobbyist | Covered position, as disclosed |
|---|---|
| MATTHEW BERZOK | LD,Chief Counsel,LA Rep. Stupak,LA Rep.Deutsch |
| RODNEY HOPPE | Deputy Press Secretary, Energy and Commerce |
| JEFF MACKINNON | LD and LA Rep. Joe Barton (R-Texas) |
| DOUGLAS R NAPPI | Chief Counsel, Senate Banking Committee |
| WILLIAM D PHILLIPS | — |
| THOMAS RYAN | — |
| JOSEPH V VASAPOLI | Min.Counsel, Energy&Comm, Special Assist. DOE |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.